EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neonatal but not juvenile gene therapy reduces seizures and prolongs lifespan in SCN1B–Dravet syndrome mice

Chunling Chen, Yukun Yuan, Heather A O'Malley, Robert Duba-Kiss, Yan Chen, Karl Habig, Yosuke Niibori, Samantha L Hodges, David R Hampson, Lori L Isom

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci182584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Chunling Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Epilepsies, Myoclonic, Seizures, Voltage-Gated Sodium Channel beta-1 Subunit. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NINDS, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dravet syndrome (DS) is a developmental and epileptic encephalopathy (DEE) that begins in the first year of life. While most cases of DS are caused by variants in SCN1A , variants in SCN1B , encoding voltage-gated sodium channel β1 subunits, are also linked to DS or to the more severe early infantile DEE. Both disorders fall under the OMIM term DEE52. Scn1b- null mice model DEE52, with spontaneous generalized seizures and death in 100% of animals in the third postnatal week. Scn1b- null cortical parvalbumin-positive interneurons and pyramidal neurons are hypoexcitable. The goal of this study was to develop a proof-of-principle gene replacement strategy for DEE52. We tested an adeno-associated viral vector encoding β1 subunit cDNA (AAV-Navβ1) in Scn1b- null mice. We demonstrated that AAV-Navβ1 drives β1 protein expression in excitatory and inhibitory neurons in mouse brains. Bilateral intracerebroventricular administration of AAV-Navβ1 in Scn1b- null mice at postnatal day 2 (P2), but not at P10, reduced spontaneous seizure severity and duration, prolonged lifespan, prevented hyperthermia-induced seizures, and restored cortical neuron excitability. AAV-Navβ1 administration to WT mice resulted in β1 overexpression in brain but no obvious adverse effects. This work lays the foundation for future development of a gene therapeutic strategy for patients with SCN1B -linked DEE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyEpilepsies, MyoclonicSeizuresVoltage-Gated Sodium Channel beta-1 SubunitLongevityAnimalsMiceMice, KnockoutAnimals, NewbornDisease Models, Animal

Stichwörter der Autor:innen

EpilepsyMouse modelsNeuroscienceSodium channelsTherapeutics

Substanzen

Voltage-Gated Sodium Channel beta-1 SubunitScn1b protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Department of Pharmacology and Toxicology and.
  • Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada.

Förderung

  • NINDS NIH HHS
  • NINDS
  • Canadian Institutes of Health Research
  • Canadian Rare Diseases Models and Mechanisms Network

Zitieren

APA

Chen, C., Yuan, Y., O'Malley, H. A., Duba-Kiss, R., Chen, Y., Habig, K., Niibori, Y., Hodges, S. L., Hampson, D. R., & Isom, L. L. (2025). Neonatal but not juvenile gene therapy reduces seizures and prolongs lifespan in SCN1B–Dravet syndrome mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci182584

Vancouver

Chen C, Yuan Y, O'Malley HA, Duba-Kiss R, Chen Y, Habig K, et al. Neonatal but not juvenile gene therapy reduces seizures and prolongs lifespan in SCN1B–Dravet syndrome mice. Journal of Clinical Investigation. 2025. doi:10.1172/jci182584

BibTeX
@article{Chen2025,
  author = {Chen, Chunling and Yuan, Yukun and O'Malley, Heather A and Duba-Kiss, Robert and Chen, Yan and Habig, Karl and Niibori, Yosuke and Hodges, Samantha L and Hampson, David R and Isom, Lori L},
  title = {Neonatal but not juvenile gene therapy reduces seizures and prolongs lifespan in SCN1B–Dravet syndrome mice},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci182584}
}
Kostenlos starten →